Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ross J Harris

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
Research Synthesis Methods|June 12, 2015
Development of a combined database for meta-epidemiological researchJelena Savović, Ross J Harris, Lesley Wood, et al.
The International Journal on Drug Policy|November 16, 2025
Using modelling and public health surveillance data to evidence progress towards the WHO incidence target for hepatitis C elimination in people who inject drugs - a review of complementary approaches in the United KingdomHolly D Mitchell, India Clancy, Daniela De Angelis, et al.
The Lancet. Public Health|March 26, 2022
Effectiveness of nationwide programmatic testing and treatment for latent tuberculosis infection in migrants in England: a retrospective, population-based cohort studyLuis C Berrocal-Almanza, Ross J Harris, Simon M Collin, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|July 5, 2024
Pilot postal birth cohort hepatitis C virus screening in UK primary care: HepCAPP studyRuth Simmons, Annabel A Powell, Samreen Ijaz, et al.
The International Journal on Drug Policy|June 28, 2024
Evaluating the effect of direct-acting antiviral agent treatment scale-up on Hepatitis C virus prevalence among people who inject drugs in UKPantelis Samartsidis, Ross J Harris, John Dillon, et al.
The Journal of Infection|March 26, 2021
Serological surveillance of SARS-CoV-2: Six-month trends and antibody response in a cohort of public health workersRoss J Harris, Heather J Whitaker, Nick J Andrews, et al.
Antiviral Therapy|February 7, 2009
Prognostic importance of anaemia in HIV type-1-infected patients starting antiretroviral therapy: collaborative analysis of prospective cohort studiesRoss J Harris, Jonathan A C Sterne, Sophie Abgrall, et al.
Annals of Internal Medicine|September 5, 2012
Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trialsJelena Savović, Hayley E Jones, Douglas G Altman, et al.
The European Respiratory Journal|August 3, 2019
Fluoroquinolones and isoniazid-resistant tuberculosis: implications for the 2018 WHO guidanceHelen R Stagg, Graham H Bothamley, Jennifer A Davidson, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Research Synthesis Methods|June 12, 2015
Development of a combined database for meta-epidemiological researchJelena Savović, Ross J Harris, Lesley Wood, et al.
The International Journal on Drug Policy|November 16, 2025
Using modelling and public health surveillance data to evidence progress towards the WHO incidence target for hepatitis C elimination in people who inject drugs - a review of complementary approaches in the United KingdomHolly D Mitchell, India Clancy, Daniela De Angelis, et al.
The Lancet. Public Health|March 26, 2022
Effectiveness of nationwide programmatic testing and treatment for latent tuberculosis infection in migrants in England: a retrospective, population-based cohort studyLuis C Berrocal-Almanza, Ross J Harris, Simon M Collin, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|July 5, 2024
Pilot postal birth cohort hepatitis C virus screening in UK primary care: HepCAPP studyRuth Simmons, Annabel A Powell, Samreen Ijaz, et al.
The International Journal on Drug Policy|June 28, 2024
Evaluating the effect of direct-acting antiviral agent treatment scale-up on Hepatitis C virus prevalence among people who inject drugs in UKPantelis Samartsidis, Ross J Harris, John Dillon, et al.
The Journal of Infection|March 26, 2021
Serological surveillance of SARS-CoV-2: Six-month trends and antibody response in a cohort of public health workersRoss J Harris, Heather J Whitaker, Nick J Andrews, et al.
Antiviral Therapy|February 7, 2009
Prognostic importance of anaemia in HIV type-1-infected patients starting antiretroviral therapy: collaborative analysis of prospective cohort studiesRoss J Harris, Jonathan A C Sterne, Sophie Abgrall, et al.
Annals of Internal Medicine|September 5, 2012
Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trialsJelena Savović, Hayley E Jones, Douglas G Altman, et al.
The European Respiratory Journal|August 3, 2019
Fluoroquinolones and isoniazid-resistant tuberculosis: implications for the 2018 WHO guidanceHelen R Stagg, Graham H Bothamley, Jennifer A Davidson, et al.
Pageof 4